✦ LIBER ✦

14-115 - The efficacy of ziprasidone in schizophrenia and schizoaffective disorder: An update

✍ Scribed by E. Keck Jr.; Edmund P. Harrigan; Karen R. Reeves

Book ID: 118511511
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 280 KB
Volume: 42
Category: Article
ISSN: 0006-3223
DOI: 10.1016/s0006-3223(97)87054-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The efficacy and safety of 28-day treatm

The efficacy and safety of 28-day treatment with ziprasidone in schizophrenia/schizoaffective disorder

✍ E. Harrigan 📂 Article 📅 1996 🏛 Elsevier Science 🌐 French ⚖ 132 KB

P-22-8 - The efficacy and safety of 28-d

P-22-8 - The efficacy and safety of 28-day treatment with ziprasidone in schizophrenia/schizoaffective disorder

✍ E. Harrigan 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 281 KB

Double-blind comparison of the safety an

Double-blind comparison of the safety and efficacy of lurasidone and ziprasidone in clinically stable outpatients with schizophrenia or schizoaffective disorder

✍ Steven G. Potkin; Masaaki Ogasa; Josephine Cucchiaro; Antony Loebel 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 444 KB

Effects of Oral Ziprasidone and Oral Hal

Effects of Oral Ziprasidone and Oral Haloperidol on QTc Interval in Patients with Schizophrenia or Schizoaffective Disorder

✍ Dr. Jeffrey J. Miceli; Dr. Thomas G. Tensfeldt; Dr. Thomas Shiovitz; Dr. Richard 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB

P.3.c.056 Efficacy of ziprasidone in the

P.3.c.056 Efficacy of ziprasidone in the treatment of schizoaffective disorder:an analysis of 2 fixed-dose, placebo-controlled trials

✍ F. Rappard; L.E. Warrington; I. Lombardo; I. Loebel; R. Yang 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Efficacy and safety of long-acting rispe

Efficacy and safety of long-acting risperidone in elderly patients with schizophrenia and schizoaffective disorder

✍ Robert A. Lasser; Cynthia A. Bossie; Young Zhu; Georges Gharabawi; Mariëlle Eerd 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views

## Abstract ## Background Elderly patients are often an underserved population in terms of optimizing treatment outcomes. Long‐acting risperidone, the first long‐acting injectable atypical antipsychotic, can improve outcomes through continuous medication delivery. ## Objective To assess the effi